Skip to main content
. 2014 Feb 17;35(6):1276–1283. doi: 10.1093/carcin/bgu028

Table IV.

Association between iron intake and advanced colorectal adenoma and colorectal cancer risk stratified by genotypes possessing iron–SNP interactions P ≤ 0.10

Gene SNP Genotype Q1 Q2 Q3 Q4 P trend c P trend b,c P interaction c
Cases/ controls REF Cases/ controls OR (95% CI)a OR (95% CI)b Cases/ controls OR(95% CI)a OR (95% CI)b Cases/ controls OR(95% CI)a OR (95% CI)b
Advanced colorectal adenoma
Dietary iron
HEPHL1 rs7946162 AA 108/111 1.00 120/103 1.20 (0.82, 1.74) 1.44 (0.94, 2.19) 86/111 0.80 (0.54, 1.18) 1.19 (0.73, 1.94) 113/110 1.06 (0.72, 1.55) 2.22 (1.15, 4.27) 0.87 0.03 0.10
AG+GG 227/214 1.00 199/235 0.78 (0.60, 1.02) 0.88 (0.66, 1.18) 169/245 0.63 (0.48, 0.83) 0.81 (0.57, 1.15) 166/228 0.64 (0.48, 0.85) 0.98 (0.62, 1.55) 0.002 0.93
HEPHL1 rs2460063 TT 111/124 1.00 129/114 1.27 (0.89, 0.82) 1.51 (1.01, 2.26) 90/118 0.85 (0.58, 1.25) 1.26 (0.78, 2.03) 116/113 1.15 (0.79, 1.68) 2.39 (1.26, 4.54) 0.82 0.02 0.04
TC+CC 225/211 1.00 197/230 0.79 (0.60, 1.03) 0.89 (0.66, 1.19) 169/244 0.63 (0.48, 0.83) 0.15 (0.57, 1.15) 163/229 0.63 (0.47, 0.84) 0.95 ( 0.60, 1.50) 0.001 0.94
HEPHL1 rs7127348 GG 105/108 1.00 113/105 1.11 (0.76, 1.63) 1.37 (0.90, 2.10) 83/108 0.79 (0.53, 1.18) 1.26 (0.76, 2.07) 109/108 1.05 (0.71, 1.57) 2.40 (1.23, 4.67) 0.96 0.02 0.09
GA+GG 232/228 1.00 214/239 0.86 (0.66, 1.12) 0.97 (0.73, 1.29) 176/255 0.66 (0.50, 0.86) 0.83 (0.59, 1.17) 173/237 0.68 (0.51, 0.90) 0.83 (0.64, 1.58) 0.03 0.95
TFR2 rs4729598 CC 269/283 1.00 255/277 0.95 (0.75, 1.21) 1.05 (0.81, 1.37) 199/289 0.70 (0.54, 0.89) 0 .91 (0.66, 1.24) 221/255 0.86 (0.66, 1.10) 1.31 (0.86, 1.98) 0.11 0.21 0.07
CT+TT 68/53 1.00 72/68 0.84 (0.51, 1.37) 1.08 (0.62, 1.89) 60/74 0.68 (0.41, 1.13) 1.09 (0.57, 2.08) 61/88 0.58 (0.35, 0.96) 1.37 (0.59, 3.20) 0.03 0.45
Heme iron
ACO1 rs1041320 AA 262/338 1.00 286/328 1.12 (0.89, 1.41) 1.05 (0.83, 1.34) 312/331 1.30 (1.03, 1.64) 1.20 (0.93, 1.54) 328/358 1.24 (0.98, 1.57) 1.14 ( 0.85, 1.54) 0.10 0.42 0.03
AC+CC 4/14 1.00 4/9 2.21 (0.34, 14.5) 7.25 (0.30, 175.87) 4/7 3.67 ( 0.50, 14.52) 82.20 (0.60, 2492.20) 5/2 19.27 (1.66, 223.07) 118440.40 (29.66, 4.73e+08) 0.02 0.004
CYBRD1 rs16859443 GG 243/332 1.00 274/324 1.15 (0.91, 1.46) 1.09 (0.86, 1.40) 302/327 1.35 (1.07, 1.71) 1.25 (0.97, 1.62) 324/345 1.36 (1.07, 1.73) 1.26 (0.93, 1.70) 0.02 0.16 0.08
GA+AA 23/20 1.00 15/13 0.80 (0.29, 2.22) 0.66 (0.20, 2.19) 14/11 0.98 ( 0.33, 2.86) 0.49 (0.20, 2.19) 9/15 0.36 (0.11, 1.19) 0.26 (0.04, 1.56) 0.10 0.15
HFE rs1799945 CC 203/277 1.00 214/266 1.06 (0.82. 1.23) 1.01 (0.77, 1.32) 228/262 1.25 (0.96, 1.63) 1.17 (0.88, 1.56) 248/258 1.33 (1.02, 1.76) 1.33 (0.95, 1.86) 0.03 0.07 0.09
CG+GG 63/75 1.00 76/71 1.36 (0.85, 2.19) 1.30 (0.80, 2.13) 88/76 1.53 (0.95, 2.45) 1.36 (0.81, 2.28) 85/102 1.13 (0.70, 1.84) 0.80 (0.43, 1.48) 0.93 0.19
IREB2 rs7183034 CC 72/125 1.00 78/90 1.46 (0.95, 2.24) 1.41 (0.90, 2.21) 95/101 1.75 (1.16, 2.65) 1.58 (1.01, 2.47) 98/94 1.86 (1.22, 2.86) 1.55 (0.90, 2.66) 0.009 0.200 0.03
CT+TT 193/227 1.00 212/247 1.01 (0.77, 1.32) 0.95 (0.72, 1.26) 220/236 1.16 (0.88, 1.53) 1.10 (0.81, 1.48) 235/266 1.09 (0.82, 1.45) 1.06 (0.74, 1.51) 0.52 0.66
Colorectal cancer
Total iron
IGFBP3 rs2453839 TT 66/77 1.00 57/52 1.34 (0.81, 2.22) 1.53 (0.87, 2.68) 57/58 1.14 (0.70, 1.87) 1.24 (0.72, 2.12) 51/46 1.29 (0.76, 2.17) 1.62 (0.86, 3.05) 0.47 0.28 0.08
TC+CC 41/40 1.00 36/28 1.24 (0.63, 2.42) 1.13 (0.53, 2.41) 27/53 0.47 (0.24, 0.90) 0.42 (0.21, 0.83) 35/46 0.68 (0.36, 1.29) 0.62 (0.28, 1.35) 0.05 0.03
Dietary iron
CYBRD1 rs12052537 CC 49/64 1.00 62/74 0.98 (0.60, 1.61) 1.18 (0.67, 2.08) 48/71 1.54 (0.91, 2.59) 2.17 (1.10, 4.29) 65/45 1.14 (0.67. 1.93) 2.00 (0.80, 5.04) 0.43 0.10 0.04
CA+AA 37/30 1.00 40/38 1.41 (0.70, 2.83) 1.46 (0.69, 3.12) 36/35 0.75 (0.37, 1.50) 0.64 (0.28, 1.47) 28/34 0.74 (0.37, 1.49) 0.53 (0.19, 1.50) 0.19 0.12
FTL rs8104760 TT 79/87 1.00 96/109 1.24 (0.83, 1.86) 1.26 (0.81, 1.97) 76/97 1.14 (0.75, 1.75) 1.14 (0.67, 1.93) 84/76 0.94 (0.61, 1.45) 0.92 (0.46, 1.84) 0.63 0.66 0.06
TG+GG 8/8 1.00 8/6 1.17 (0.23, 5.99) 1.49 (0.19, 11.84) 9/11 2.69 (0.53, 13.74) 6.77 (0.72, 63.93) 10/17 2.34 (0.48, 11.42) 11.81 ( 0.61, 228.94) 0.21 0.06
HAMP rs916145 GG 67/76 1.00 79/88 1.31 (0.84, 20.4) 1.51 (0.92, 2.47) 60/94 1.50 (0.95, 2.38) 1.85 (1.03, 3.31) 67/65 1.25 (0.77, 2.03) 1.74 (0.81, 3.77) 0.36 0.20 0.10
GC+CC 20/19 1.00 25/27 1.02 (0.42, 2.45) 0.77 (0.29, 2.06) 25/14 0.75 (0.37, 1.50) 0.38 (0.13, 1.17) 27/18 0.74 (0.37, 1.49) 0.26 (0.07, 1.05) 0.06 0.04
TFRC rs7645812 CC 74/83 1.00 87/99 1.27 (0.83, 0.95) 1.38 (0.86, 2.19) 74/93 1.35 (0.86, 2.11) 1.55 (0.90, 2.68) 85/71 1.28 (0.82, 2.01) 1.57 (0.77, 3.19) 0.34 0.27 0.02
CT+TT 13/12 1.00 17/16 1.37 (0.48, 3.96) 1.58 (0.43, 5.78) 11/15 0.65 (0.22, 1.994) 0.70 (0.17, 2.88) 9/12 0.22 (0.06, 0.79) 0.30 (0.04, 2.23) 0.02 0.16
Heme iron
ACO1 rs10970985 GG 27/44 1.00 43/50 1.32 (0.70, 2.50) 1.51 (0.75, 3.02) 42/43 1.84 (0.96, 3.56) 2.50 (1.21, 5.13) 50/40 2.45 (1.23, 4.85) 3.40 (1.43, 8.06) 0.009 0.004 0.05
GC+CC 60/51 1.00 60/63 0.82 (0.49, 1.40) 0.74 (0.42, 1.29) 43/64 0.56 (0.32, 0.97) 0.50 (0.27, 0 .92) 43/42 0.85 (0.45, 1.58) 0.56 (0.25, 1.25) 0.58 0.15
HMOX1 rs737777 GG 81/84 1.00 88/93 0.95(0.62, 1.46) 0.94 (0.60, 1.47) 73/88 0.92 (0.59, 1.43) 0.97 (0.60, 1.56) 74/71 1.17 (0.72, 1.90) 1.08 (0.59, 1.96) 0.46 0.74 0.10
GT+TT 5/11 1.00 16/22 1.85 (0.53, 6.57) 2.66 (0.60, 11.85) 12/20 1.41 (0.38, 5.20) 2.29 (0.49, 10.59) 19/12 4.39 (1.09, 17.65) 14.91 (2.13, 104.69) 0.03 0.008

aAssuming a dominant model, adjusted for age, race and ethnicity.

bAssuming a dominant model, adjusted for age, race, ethnicity, education, body mass index, cigarette smoking, use of aspirin and ibuprofen, physical activity, study center, total calories, dietary fiber, dietary calcium, alcohol and family history of colorectal cancer.

cNo associations were significant after adjustment for multiple comparison testing.